Human platelet lysate (HPL) is serum derived from platelets which acts as an effective substitute for Fetal Bovine Serum (FBS) in cell culture applications. It supports growth of various cell types in culture, including mesenchymal stem cells, endothelial cells, and keratinocytes. The use of HPL avoids issues related to animal welfare, batch-to-batch variability, and regulatory hurdles associated with FBS.
The global Human Platelet Lysate Market is estimated to be valued at US$ 53.0 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased consumption as a substitute for FBS is one of the key trends driving the growth of the human platelet lysate market. HPL provides stable growth environment for culturing stem cells and other cells, has low batch-to-batch variability and is cost effective over the long run compared to FBS. It avoids problems related to transmissible spongiform encephalopathy risks and animal suffering associated with FBS. The substitutes market is growing as researchers prefer using animal-free solutions in experiments. Advancements in platelet separation technologies have further improved the efficiency and availability of human platelet lysate products, making them a preferable substitute to FBS in cell-based therapeutics and research.
Segment Analysis
The Global Human Platelet Lysate Market Demand is dominated by the autologous segment. The autologous segment currently holds around 80% of the overall market share owing to the reduced risk of transfusion-transmitted infections and immune reactions associated with autologous platelet lysate products. Several growth factors and cytokines present in autologous platelet lysate promote cell growth and proliferation making it a suitable culture medium for cell-based therapies.
Key Takeaways
Regional analysis: Europe dominates the global human platelet lysate market with over 40% market share. Presence of favorable government regulations and investments to support tissue engineering and regenerative medicine research in countries like Germany, UK, and France have promoted the adoption of human platelet lysate products in the region.
Key players: Key players operating in the human platelet lysate market are STEMCELL Technologies Inc., Merck KGaA, Mill Creek Life Sciences, Merck & Co., Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec, Life Science Group Ltd., BBI Solutions, Regenexx, Thermo Fisher Scientific. STEMCELL Technologies Inc. and Merck KGaA currently account for over 35% of the global market share due to their diverse product portfolio and strong distribution network across major markets.
The global human platelet lysate market is expected to witness high growth over the forecast period of 2023-2030. Rapid expansion of cell-based therapies and regenerative medicine sector has accelerated the demand for human platelet lysate as an alternative to fetal bovine serum. Stringent regulatory norms favoring xeno-free cell culture practices is further promoting adoption of human platelet lysate products.
Get more insights on this topic:
https://www.marketwebjournal.com/human-platelet-lysate-market-market-size-and-share-analysis/
The newly added Human Platelet Lysate market research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2027.
Further, this report also highlights smart strategy adopted by major players and also their market share.
Basically, this report is designed to give a proper understanding of industry structure and competition intensity attractiveness.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Human Platelet Lysate market include Mill Creek Life Sciences, LLC, Merck & Co., Inc., STEMCELL Technologies Inc., AventaCell BioMedical, Compass Biomedical, Inc., Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Human Platelet Lysate Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/human-platelet-lysate-market/download-sample Market DynamicsDrastic reduction in adopting animal-based serums for cell culture in experimental and clinical trials will be the primary trending factor for this market's growth.
Increased government spending on research and development of pharmaceutical and biotechnology drugs and emerging uses of this animal component-free supplement in cell therapy or regenerative medicine will boost the market growth.
The Human Platelet Lysate Market Research Report Forecast is a valuable source of insightful data for business strategists.
It provides the industry overview with recent trends, size, share, growth analysis, historical, futuristic data, revenue, demand and strategic development.The report segments the anthracite market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.Request a FREE Sample Copy of Global Human Platelet Lysate Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/human-platelet-lysate-market/download-sampleBy Product TypeHuman Platelet Lysate with HeparinHeparin-Free Human Platelet LysateBy ApplicationResearchClinicalBy End-UserBiopharmaceutical CompaniesContract Research OrganizationsAcademic & Research InstitutesPharmaceutical CompaniesOthersBrowse Full Global Human Platelet Lysate Market Research Report With TOC At: https://www.valuemarketresearch.com/report/human-platelet-lysate-marketThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Human Platelet Lysate market include Mill Creek Life Sciences, LLC, Merck & Co., Inc., STEMCELL Technologies Inc., AventaCell BioMedical, Compass Biomedical, Inc., Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for Human Platelet Lysate market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Further, the report focuses on demand for individual application segment across all the prominent regions.Purchase complete Global Human Platelet Lysate Market Research Report At: https://www.valuemarketresearch.com/contact/human-platelet-lysate-market/buy-nowAbout Us:Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.Contact:Value Market Research401/402, TFM, Nagras Road, Aundh, Pune-7.Maharashtra, INDIA.Tel: +1-888-294-1147Email: [email protected]: https://www.valuemarketresearch.com
The‘Global Human Platelet Lysate Market Report’ is a comprehensive and in-depth study on the size, share, growth,trends, demand and estimation with a focus on the latest development.
The report provides key statistics on the market status with highlights on various important strategic such as mergers, acquisitions, partnership and other development.The report segments the anthracite market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.Request a FREE Sample Copy of Global Human Platelet Lysate Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/human-platelet-lysate-market/download-sampleBy Product TypeHuman Platelet Lysate with HeparinHeparin-Free Human Platelet LysateBy ApplicationResearchClinicalBy End-UserBiopharmaceutical CompaniesContract Research OrganizationsAcademic & Research InstitutesPharmaceutical CompaniesOthersBrowse Full Global Human Platelet Lysate Market Research Report With TOC At: https://www.valuemarketresearch.com/report/human-platelet-lysate-marketThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Human Platelet Lysate market include Mill Creek Life Sciences, LLC, Merck & Co., Inc., STEMCELL Technologies Inc., AventaCell BioMedical, Compass Biomedical, Inc., Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for Human Platelet Lysate market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Further, the report focuses on demand for individual application segment across all the prominent regions.Purchase complete Global Human Platelet Lysate Market Research Report At: https://www.valuemarketresearch.com/contact/human-platelet-lysate-market/buy-nowAbout Us:Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.Contact:Value Market Research401/402, TFM, Nagras Road, Aundh, Pune-7.Maharashtra, INDIA.Tel: +1-888-294-1147Email: [email protected]: https://www.valuemarketresearch.com
